Abstract
The biological activity of a peptide-based geroprotector was studied on the basis of the calf aorta extract Slavinorm in experimental models of hyperlipidemia and acute myocardial infarction. The study results showed that Slavinorm has a pronounced antiatherogenic effect, which appeared in the optimization of the blood-lipid spectrum, including normalization of the atherogenicity factor due to an increase in the high-density lipids level and other cholesterol fractions decrease. In a model of acute myocardial infarction in rats, Slavinorm showed an antiischemic effect, which was expressed in a significant reduction in the necrotic zone after a 4-hour occlusion of the coronary artery, as compared with the parameters of the control animals, and a low incidence of postocclusion arrhythmias.
Similar content being viewed by others
References
Grigor’ev, S.G., Kireev, O.V., Kuvakin, V.I., et al., Mnogomernye metody statisticheskogo analiza kategorirovannykh dannykh meditsinskikh issledovanii (Multi-Dimensional Methods of Statistical Analysis of Categorical Data of Medical Studies), St. Petersburg: VMA, 2002, 103 p.
Korkushko, O.V., Serdechno-sosudistaya sistema i vozrast (Cardiovascular System and Age), Moscow: Meditsina, 1983.
Preferanskaya, N.G., Antiatherosclerotic Medicines, Ros. Med. Zh., 2002, no. 5, pp. 76–80.
Rakov, A.L. and Kolesnikov, V.N., Atherosclerosis, Novaya Apteka, 2002, no. 6, pp. 28–32.
Sokolov, A.A., Kovalev, I.A., Martsinkevich, G.I., and Suslova, T.E., Dysfunction of Endothelium in People with Heavy Form of Inherited Atherosclerosis, Kardiol., 2004, vol. 44, no. 1, pp. 39–44.
Kharchenko, V.I., Kakorina, E.P., Koryakin, M.V., et al., Death Rate as the Result of Blood System Diseases in Russia and Economically Developed Countries. Required Cardiological Help and Modernization of Medical Statistics in Russian Federation: Analytical Review of the Official Data of Goskomstat and the Ministry of Health and Social Development of Russia, and Expert Assessment of the Problems, Ros. Kardiol. Zh., 2005, no. 2, pp. 5–17.
Biro, S., Masuda, A., Kihara, T., and Tei, C., Obesity and Diabetes: Pathophysiological Mechanisms and Therapeutic Approaches, Exp. Biol. Med., 2003, vol. 228, pp. 1245–1249.
Oeser, J., Fehr, R., and Brinkmann, B., Aortic and Coronary Atherosclerosis in a Hamburg Autopsy Series, Virchows Archiv., 1979, vol. P, pp. 131–148.
Tsuchiya, K., Takiguchi, Y., Okamoto, M., et al., Malfunction of Vascular Control in Lifestyle-Related Diseases: Formation of Systemic Hemoglobin-Nitric Oxide Complex (HbNO) from Dietary Nitrite, J. Pharmacol. Sci., 2004, vol. 96, no. 4, pp. 395–400.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.P. Ryzhak, B.I. Kuznik, V.N. Rutkovskaya, G.A. Ryzhak, 2012, published in Uspekhi Gerontologii, 2012, Vol. 25, No. 1, pp. 139–142.
Rights and permissions
About this article
Cite this article
Ryzhak, A.P., Kuznik, B.I., Rutkovskaya, V.N. et al. The antiatherosclerotic effects of a geroprotector peptide. Adv Gerontol 2, 332–335 (2012). https://doi.org/10.1134/S2079057012040121
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079057012040121